Series B

Round names started as paperwork. The shares issued to investors were labeled Series A, Series B and so on in the order they were created, and the labels became the names of the rounds. Nothing in the name itself says how much money changes hands or what the company is worth.

What settled onto those names over time was the question each stage asks. Before they were distinct, the recurring problem was mismatched expectations: the company prepares for "the next round" as one thing while the investor is already looking at something else. At seed the question is whether the people who tried the product come back. At Series A it is whether money spent to acquire a customer returns more than it cost.

Meetings held without that distinction tended to end the same way. A founder answers that customers are sticking around, while what the investor wanted to know was whether the win rate holds after tripling the sales team. Two people discussing the same company on two different questions, each thinking the other was being evasive. The name Series B is the marker that says the question in this stretch is not whether the model works but whether it scales — and knowing that a year ahead is what lets a company collect the evidence before anyone asks for it.

Series B money goes to a company that already knows what to sell and now has to sell more of it. The spending shifts from product to people and markets.

1. Size and ownership — $10 million to $25 million is the common band, in exchange for 15 to 25 percent of the company. Valuations spread from roughly $50 million to $150 million.
2. Investors — institutional venture capital leads. The largest check usually comes with a seat on the board of directors, the body that oversees and approves major decisions, and from that point significant choices carry an outside approval step.
3. Verification — due diligence widens. Metrics get recalculated from raw data, and the firm calls major customers directly to confirm contract terms and satisfaction.
4. Numbers — conventionally the conversation works when annual recurring revenue (ARR) sits somewhere between $4 million and $8 million, net revenue retention (NRR) is at or above 100 percent, and CAC payback lands inside 18 months. The second of those shows whether expansion from existing customers covers what churn takes away.
5. Organization — headcount moves from around 50 to around 150. Hiring one person at a time turns into hiring managers who build teams, which is the first point where the founders stop meeting every new employee.

The largest line in this round is almost always sales and marketing. There is no way to spend $15 million on engineering alone. So half the fundraising deck is a hiring plan and the revenue those hires are expected to produce, and the questions that follow are about the ramp: how long a new rep takes to reach quota, and what the plan assumes happens if that takes twice as long.

Getting to Series C means showing that the money spent in this stage turned into growth that repeats. Whether it repeats matters more than how fast it grew.

1. Does selling scale with headcount. When a rep reaches quota in a known number of months and that number holds after the team doubles, the next round's plan becomes arithmetic rather than argument. If the win rate halves after the expansion, what happened was headcount growth rather than scaling, and the fix is usually in onboarding or in the definition of the target customer rather than in hiring more people.
2. Does a second axis turn. Revenue concentrated in one market or one product caps out at a known ceiling. A new region or a new product line has to produce repeat revenue, not a first sale.
3. Did growth per dollar burned improve. A burn multiple better than at Series A says the company learned how to spend; worse says it is buying the same growth at a higher price.
4. Does it run without the founder. A company where every significant decision routes through the CEO doesn't triple its throughput by tripling its headcount.

When those conditions are thin and the cash balance drops first, the outcome is a bridge round to buy a few months, or a down round at a reduced valuation.

"We're prepping the Series B and investors only want to talk about the second market."

Results from one market don't answer the question this stage asks.

"You can't really call these terms a Series B. It's a bridge."

The amount and the structure aren't the shape of a priced round.

"Series B is money for people. You can't spend that much on product work alone."

Explaining where the round is meant to go.

Pagedeck just closed its Series A, so it isn't in this stretch yet. Grace has decided to start building the second axis now with a view to 18 months out: revenue from enterprise accounts has to be counted separately from what individuals and small teams bring in.

So Sofia manages enterprise contracts as their own book, and Mia has moved the permission controls those accounts ask for to the front of the roadmap. Eighteen months is roughly how long it takes for that second line to be long enough to read.

The first assumption is that the name determines the amount or the valuation. Say Series B and a figure already comes to mind. But it is an ordinal label, so the same $7.5 million is a Series A at one company and a Series B at another. What has been proven sets the stage, and the amount follows from it. Treat the name as the standard and a company that hasn't proven its model raises an amount that matches and calls it a B — then takes the earlier stage's questions again in the next round.

The second is that reaching Series B means the dangerous stretch is over. Money arrived and the organization grew, so it feels settled. But failure in this stage costs more than it did earlier. Triple the team and miss the growth plan, and reversing it takes both money and time. A thirty-person company changing direction and a 150-person company doing the same thing are not the same maneuver — the second one involves commitments, reporting lines and severance that the first one never had.